Personensuche
Personensuche
Es wurde 1 Person gefunden.
E-Mail
Funktionen
-
apl. Professor/in und Privatdozent/in, Klinik für Endokrinologie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsIn: Acta Neuropathologica , Jg. 149 2025 , Nr. 1 , 4DOI (Open Access)
-
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas : A Pituitary Society international Consensus StatementIn: Nature Reviews Endocrinology , Jg. 20 2024 , Nr. 1 , 62
-
Evidence for somatic mutation screening on aggressive prolactinomasIn: Nature Reviews Endocrinology , Jg. 20 2024 , Nr. 10 , S. 565 - 566
-
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumorsIn: Acta Neuropathologica , Jg. 148 2024 , Nr. 1 , 68DOI (Open Access)
-
Reply to ‘The shift of therapeutic strategy for prolactinomas: surgery as the first-line option’In: Nature Reviews Endocrinology , Jg. 20 2024 , Nr. 5 , S. 311
-
Reply to ‘Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern’In: Nature Reviews Endocrinology , Jg. 20 2024 , Nr. 5 , S. 315
-
Transition from Paediatric to Adult Care in CAH : 20 Years of Experience at a Tertiary Referral CenterIn: Hormone and Metabolic Research , Jg. 56 2024 , Nr. 1 , S. 45 - 50
-
Diagnosis and management of prolactin-secreting pituitary adenomas : A Pituitary Society international Consensus StatementIn: Nature Reviews Endocrinology , Jg. 19 2023 , Nr. 12 , S. 722 - 740
-
Diagnosis and management of hypertension in patients with Cushing's syndrome : a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionIn: Journal of Hypertension , Jg. 40 2022 , Nr. 11 , S. 2085 - 2101
-
Consensus on diagnosis and management of Cushing's disease : A guideline updateIn: The Lancet Diabetes and Endocrinology , Jg. 9 2021 , Nr. 12 , S. 847 - 875DOI (Open Access)
-
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and SwitzerlandIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 129 2021 , Nr. 3 , S. 224 - 233DOI (Open Access)
-
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and AustriaIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 129 2021 , Nr. 07 , S. 500 - 509DOI (Open Access)
-
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas -A German SurveyIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 105 2020 , Nr. 3 , S. e660 - e675DOI (Open Access)
-
Pituitary Disease in Pregnancy : Special Aspects of Diagnosis and Treatment?In: Geburtshilfe und Frauenheilkunde , Jg. 79 2019 , Nr. 4 , S. 365 - 374DOI (Open Access)
-
Aggressive pituitary tumours and carcinomas : two sides of the same coin?In: European Journal of Endocrinology (EJE) , Jg. 178 2018 , Nr. 6 , S. C7 - C9
-
Black swans - neuroendocrine tumors of rare locationsIn: Reviews in Endocrine and Metabolic Disorders , Jg. 19 2018 , Nr. 2 , S. 111 - 121
-
Efficacy and safety of once-monthly pasireotide in Cushing's disease : a 12 month clinical trialIn: The Lancet Diabetes and Endocrinology , Jg. 6 2018 , Nr. 1 , S. 17 - 26DOI (Open Access)
-
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomasIn: European Journal of Endocrinology (EJE) , Jg. 178 2018 , Nr. 1 , S. G1 - G24DOI (Open Access)
-
MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma : PRIMARYS post-hoc analysisIn: European Journal of Endocrinology (EJE) , Jg. 180 2018 , Nr. 3 , S. 155 - 164DOI (Open Access)
-
Neuroendocrine neoplasms - think about it and choose the most appropriate diagnostic and therapeutic stepsIn: Reviews in Endocrine and Metabolic Disorders , Jg. 19 2018 , Nr. 2 , S. 107 - 109DOI (Open Access)
-
Pituitary disease management during pregnancy : an overviewIn: Minerva Endocrinologica , Jg. 43 2018 , Nr. 4 , S. 420 - 422
-
Secondary adrenal insufficiency in pregnancy : any differences?In: Minerva Endocrinologica , Jg. 43 2018 , Nr. 4 , S. 446 - 450
-
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenomaIn: Hypertension , Jg. 71 2018 , Nr. 2 , S. 317 - 325DOI (Open Access)
-
Treatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016In: European Journal of Endocrinology (EJE) , Jg. 178 2018 , Nr. 3 , S. 265 - 276
-
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed PreventionIn: JAMA Oncology , Jg. 3 2017 , Nr. 9 , S. 1204 - 1212DOI (Open Access)
-
Diagnostik und Therapie der Akromegalie : Notwendigkeit der gezielten Überwachung von KomorbiditätenIn: Der Internist , Jg. 58 2017 , Nr. 11 , S. 1171 - 1182
-
Erratum : Histological criteria for atypical pituitary adenomas--data from the German pituitary adenoma registry suggests modificationsIn: Acta Neuropathologica Communications , Jg. 4 2016 , S. 21
-
Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas : analysis of the German ACC registryIn: European Journal of Endocrinology (EJE) , Jg. 172 2015 , Nr. 4 , S. 415 - 422
-
Erratum: Total Testosterone and Calculated Estimates for Free and Bioavailable Testosterone: Influence of Age and Body Mass Index and Establishment of Sex-Specific Reference RangesIn: Hormone and Metabolic Research , Jg. 47 2015 , Nr. 11 , S. e5
-
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modificationsIn: Acta Neuropathologica Communications , Jg. 3 2015 , S. 50DOI (Open Access)
-
How to manage pasireotide, when using as medical treatment for Cushing's diseaseIn: Endocrine , Jg. 50 2015 , Nr. 3 , S. 526 - 528
-
Pituitary-directed medical therapy in Cushing's diseaseIn: Pituitary , Jg. 18 2015 , Nr. 2 , S. 238 - 244
-
Qualitätssicherung der Analytik von Wachstumshormon und Insulin-Like Growth Factor I bei Erkrankungen der somatotropen AchseIn: Laboratoriumsmedizin , Jg. 39 2015 , Nr. 2 , S. 81 - 86
-
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer : Results from the European EURAF CohortIn: Annals of Oncology , Jg. 26 2015 , Nr. S 1: European Lung Cancer Conference (ELCC), Geneva, Switzerland, 15-18 April 2015 : Abstracts , S. i61
-
Total testosterone and calculated estimates for free and bioavailable testosterone : Influence of age and body mass index and establishment of sex-specific reference rangesIn: Hormone and Metabolic Research , Jg. 47 2015 , Nr. 11 , S. 846 - 854
-
Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine : own experience and overview of the contemporary literatureIn: Clinical Endocrinology , Jg. 82 2015 , Nr. 1 , S. 84 - 90
-
Erratum to : Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension studyIn: Pituitary , Jg. 17 2014 , Nr. 2 , S. 141
-
Expression Analysis of GADD45γ, MEG3, and p8 in Pituitary AdenomasIn: Hormone and Metabolic Research , Jg. 46 2014 , Nr. 9 , S. 644 - 650
-
High variability in baseline urinary free cortisol values in patients with Cushing's diseaseIn: Clinical Endocrinology , Jg. 80 2014 , Nr. 2 , S. 261 - 269DOI (Open Access)
-
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly : results from an open-ended, multicenter, Phase II extension studyIn: Pituitary , Jg. 17 2014 , Nr. 2 , S. 132 - 140DOI (Open Access)
-
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease : results from a Phase III studyIn: Clinical Endocrinology , Jg. 81 2014 , Nr. 3 , S. 408 - 417
-
Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly : a randomized, multicenter, open-label, phase I studyIn: Journal of Clinical Pharmacology , Jg. 54 2014 , Nr. 11 , S. 1308 - 1317
-
Sagit© : A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical PracticeIn: Value in Health , Jg. 17 2014 , Nr. 7 , S. A355
-
Somatuline Autogel treatment in Acromegaly-1 year data from SOPRANo studyIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 122 2014 , Nr. 3 , S. P125
-
Spontaneous course of hypophysitis - data from a survey of the German Pituitary Working GroupIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 122 2014 , Nr. 3 , OP7_33
-
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly : results of a prospective multicenter clinical trialIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 99 2014 , Nr. 4 , S. 1282 - 1290DOI (Open Access)
-
Cardiac risk in patients with treatment naïve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general populationIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 121 2013 , Nr. 2 , S. 125 - 132
-
Cardiovascular risk in patients with hypopituitarism after surgery: comparison to matched data from the general populationIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 121 2013 , S. P65
-
New avenues in the medical treatment of Cushing's disease : corticotroph tumor targeted therapyIn: Journal of Neuro-Oncology , Jg. 114 2013 , Nr. 1 , S. 1 - 11DOI (Open Access)
-
Preliminary Testing of the Sagit Tool : A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical PracticeIn: Value in Health , Jg. 16 2013 , Nr. 7 , S. A447DOI (Open Access)
-
Screening for Cushing's Syndrome : New Immunoassays Require Adequate Normative DataIn: Hormone and Metabolic Research , Jg. 45 2013 , Nr. 2 , S. 118 - 123
-
Treatment with temozolomide in aggressive pituitary tumors - data from a survey by the German Pituitary Study GroupIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 121 2013 , Nr. 3 , OP1_02
-
A 12-Month Phase 3 Study of Pasireotide in Cushing's DiseaseIn: The New England Journal of Medicine , Jg. 366 2012 , Nr. 10 , S. 914 - 924
-
Automated 22-kD Growth Hormone–Specific Assay without Interference from PegvisomantIn: Clinical Chemistry , Jg. 58 2012 , Nr. 10 , S. 1446 - 1456
-
Differential expression of somatostatin receptor subtype 1-5 proteins in numerous human normal tissuesIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 120 2012 , Nr. 8 , S. 482 - 489
-
Effects of standard glucocorticoid replacement therapies on subjective well-being : A randomized, double-blind, crossover study in patients with secondary adrenal insufficiencyIn: European Journal of Endocrinology (EJE) , Jg. 167 2012 , Nr. 5 , S. 679 - 685
-
Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomasIn: Clinical Endocrinology , Jg. 77 2012 , Nr. 1 , S. 139 - 145
-
Medical management of Cushing's disease : what is the future?In: Pituitary , Jg. 15 2012 , Nr. 3 , S. 330 - 341
-
Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male VolunteersIn: Journal of Clinical Pharmacology , Jg. 52 2012 , Nr. 7 , S. 1017 - 1027
-
Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal massIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 120 2012 , Nr. 8 , S. 494 - 500
-
Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency : Improved screening by an automatic immunoassayIn: European Journal of Endocrinology (EJE) , Jg. 166 2012 , Nr. 4 , S. 613 - 618DOI (Open Access)
-
Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers : A Single-Center, Open-Label, Ascending-Dose StudyIn: Clinical Therapeutics , Jg. 34 2012 , Nr. 3 , S. 677 - 688
-
68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine TumorsIn: Journal of Nuclear Medicine (JNM) , Jg. 52 2011 , Nr. 12 , S. 1864 - 1870
-
68Ga-DOTATOC vs. 68Ga-DOTATATE PET/CT in functional imaging of Neuroendocrine TumoursIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 38 2011 , Nr. Suppl. 2 , S. 97 - S98
-
Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center ExperienceIn: Hormone and Metabolic Research , Jg. 43 2011 , Nr. 12 , S. 838 - 843
-
Efficacy and Acceptability of Lanreotide Autogel® 120 mg at Different Dose Intervals in Patients with Acromegaly Previously Treated with Octreotide LARIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 119 2011 , Nr. 3 , S. 156 - 162
-
Measurement of Urinary Free Cortisol by Current Immunoassays : Need for Sex-dependent Reference Ranges to Define HypercortisolismIn: Hormone and Metabolic Research , Jg. 43 2011 , Nr. 10 , S. 714 - 719
-
Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia : Utility of salivary 17α- hydroxyprogesterone day profilesIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 119 2011 , Nr. 3 , S. 131 - 138
-
Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine : a Single-Center ExperienceIn: Experimental and Clinical Endocrinology & Diabetes , Jg. 119 2011 , Nr. 9 , S. 540 - 543
-
⁶⁸Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV mₐₓIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 38 2011 , Nr. 7 , S. 1224 - 1236
-
Association of somatostatin receptor 2 immunohistochemical expression with [¹¹¹In]-DTPA octreotide scintigraphy and [⁶⁸Ga]-DOTATOC PET/CT in neuroendocrine tumorsIn: Hormone and Metabolic Research , Jg. 42 2010 , Nr. 8 , S. 599 - 606
-
Baseline Characteristics and Urine Free Cortisol (UFC) Variability of 162 Patients Enrolled in a Randomized, Double-Blind Phase III Study Assessing the Efficacy and Safety of Pasireotide (SOM230) in Patients with Cushings Disease
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews , Jg. 31 2010 , Nr. Suppl. 1 -
Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly : Comparison with matched data from the general population and the effect of disease controlIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 95 2010 , Nr. 8 , S. 3648 - 3656
-
Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research , Jg. 42 2010 , Nr. 1 , S. 61 - 64
-
Diagnosis of adrenal insufficiency using the GHRP-6 test : Comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal diseaseIn: Hormone and Metabolic Research , Jg. 42 2010 , Nr. 3 , S. 198 - 203
-
Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgeryIn: European Journal of Endocrinology (EJE) , Jg. 162 2010 , Nr. 3 , S. 477 - 482
-
Gibt es Hinweise auf ein Cushing-Syndrom? : Arterielle Hypertonie und AdipositasIn: MMW - Fortschritte der Medizin , Jg. 152 2010 , Nr. 7 , S. 39 - 41
-
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centersIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 95 2010 , Nr. 11 , S. 4925 - 4932
-
Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasmaIn: Clinical Endocrinology , Jg. 73 2010 , Nr. 2 , S. 153 - 160
-
Long-Term Treatment of Acromegaly with Pasireotide (SOM230) : Results from a Phase II Extension Study
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews , Jg. 31 2010 , Nr. Suppl. 1 , OR 16-5 -
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly : A randomized, multicenter, phase II trialIn: The Journal of Clinical Endocrinology & Metabolism (JCEM) , Jg. 95 2010 , Nr. 6 , S. 2781 - 2789DOI (Open Access)
-
Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s SyndromeIn: World Journal of Surgery , Jg. 34 2010 , Nr. 6 , S. 1391 - 1397
-
Prolactinomas, Cushing's disease and acromegaly : Debating the role of medical therapy for secretory pituitary adenomasIn: BMC Endocrine Disorders , Jg. 10 2010 , S. 10DOI (Open Access)
-
Randomized, Double-Blinded, Cross-Over Study Comparing Various Glucocorticoid Substitution Schemes in Secondary Adrenal Insufficiency
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews , Jg. 31 2010 , Nr. Suppl. 1 -
Recovery of pituitary function in the late-postoperative phase after pituitary surgery : Results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgeryIn: European Journal of Endocrinology (EJE) , Jg. 162 2010 , Nr. 5 , S. 853 - 859
-
The Effect of Pegvisomant on Cardiovascular Risk in Patients with Active Acromegaly in Comparison to Matched Data from the General Population
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews , Jg. 31 2010 , Nr. 3, Suppl. 1 , S. 857, OR16-6 -
The Effect of Pegvisomant on Glucose Metabolism and Insulin Levels in Healthy Adults
The Endocrine Society’s 92nd Annual Meeting & Expo, 1 June 2010,In: Endocrine Reviews , Jg. 31 2010 , Nr. Suppl. 1 , S. P3 - 250 -
The rational use of pituitary stimulation testsIn: Deutsches Ärzteblatt international , Jg. 107 2010 , Nr. 25 , S. 437 - 443DOI (Open Access)
-
Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research , Jg. 40 2008 , Nr. 3 , S. 210 - 213
-
Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research , Jg. 40 2008 , Nr. 3 , S. 181 - 188
-
Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumoursIn: Clinical Endocrinology , Jg. 68 2008 , Nr. 6 , S. 850 - 857
-
Retroperitoneoscopic Adrenalectomy in Conn’s Syndrome Caused by Adrenal Adenomas or Nodular HyperplasiaIn: World Journal of Surgery , Jg. 32 2008 , Nr. 5 , S. 847 - 853
-
Androgenproduzierender Leydig-Zell-Tumor des Ovars als Ursache von Hirsutismus bei einer postmenopausalen FrauIn: Medizinische Klinik , Jg. 102 2007 , Nr. 3 , S. 259 - 262
-
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal massIn: European Journal of Endocrinology , Jg. 154 2006 , Nr. 3 , S. 409 - 417DOI (Open Access)
-
Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: Results of 161 tumors in 126 patientsIn: World Journal of Surgery , Jg. 30 2006 , Nr. 5 , S. 899 - 908
-
Posterior retroperitoneoscopic adrenalectomy-results of 560 procedures in 520 patientsIn: Surgery , Jg. 140 2006 , Nr. 6 , S. 943 - 950
-
Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal glandIn: Hormone and Metabolic Research , Jg. 37 2005 , Nr. 12 , S. 722 - 728
-
Endoscopic treatment of large primary adrenal tumoursIn: British Journal of Surgery , Jg. 92 2005 , Nr. 6 , S. 719 - 723
-
Neuroendokrine Tumoren : Seltene medizinische PhänomeneIn: Essener Unikate: Berichte aus Forschung und Lehre 2005 , Nr. 25 : Medizin – Unsere Hormone , S. 62 - 75Online Volltext (Open Access)
-
Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumorsIn: Endocrine Research , Jg. 30 2004 , Nr. 4 , S. 931 - 934
-
Partial versus total adrenalectomy by the posterior retroperitoneoscopic approach : Early and long-term results of 325 consecutive procedures in primary adrenal neoplasiasIn: World Journal of Surgery , Jg. 28 2004 , Nr. 12 , S. 1323 - 1329
-
Neurohormone steuern das Leben : Hormone als Vermittler zwischen Zentralnervensystem und peripheren OrganenIn: Essener Unikate: Berichte aus Forschung und Lehre 2003 , Nr. 22 : Neurowissenschaften – Wir und unser Gehirn , S. 30 - 41Online Volltext (Open Access)
-
Successful transition in Congenital Adrenal Hyperplasia : A single centre experience over 20 yearsIn: Hormone Research in Paediatrics , Jg. 96 2023 , Nr. Suppl. 4 , S. 147 - 148
-
Association of Somatostatin Receptor 2 Immunohistochemical Expression with [111In]-DTPA Octreotide Scintigraphy and [68Ga]-DOTATOC PET/CT in Neuroendocrine Tumors
7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,In: Neuroendocrinology , Jg. 92 2010 , Nr. 1 , S. 47 -
Chemotherapy in the Treatment of Progressive, Undifferentiated Neuroendocrine Carcinomas : A Single-Center Experience
7th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease March 11–12, 2010 Berlin, Germany,In: Neuroendocrinology , Jg. 92 2010 , Nr. 1 , S. 27 -
Differential Uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of Gastroenteropancreatic Neuroendocrine TumorsIn: Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment / Baum, Richard P.; Rösch, Frank (Hrsg.) 2013 , S. 353 - 371